Raggi, P., Bellasi, A., Sinha, S., Bover, J., Rodriguez, M., Ketteler, M., . . . Chertow, G. M. (2020). Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.
Citación estilo ChicagoRaggi, Paolo, et al. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial. 2020.
Cita MLARaggi, Paolo, et al. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial. 2020.
Precaución: Estas citas no son 100% exactas.